Literature DB >> 10922493

Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains.

T J Hay1, D W Meek.   

Abstract

The MDM2 oncoprotein is a negative regulatory partner of the p53 tumour suppressor. MDM2 mediates ubiquitination of p53 and targets the protein to the cytoplasm for 26S proteosome-dependent degradation. In this paper, we show that MDM2 is modified in cultured cells by multisite phosphorylation. Deletion analysis of MDM2 indicated that the sites of modification fall into two clusters which map respectively within the N-terminal region encompassing the p53 binding domain and nuclear export sequence, and the central acidic domain that mediates p14(ARF) binding, p53 ubiquitination and cytoplasmic shuttling. The data are consistent with potential regulation of MDM2 function by multisite phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922493     DOI: 10.1016/s0014-5793(00)01850-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Hypophosphorylation of Mdm2 augments p53 stability.

Authors:  Christine Blattner; Trevor Hay; David W Meek; David P Lane
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

2.  Flexible lid to the p53-binding domain of human Mdm2: implications for p53 regulation.

Authors:  Mark A McCoy; Jennifer J Gesell; Mary M Senior; Daniel F Wyss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

3.  Expression of the Bcl-3 proto-oncogene suppresses p53 activation.

Authors:  David Kashatus; Patricia Cogswell; Albert S Baldwin
Journal:  Genes Dev       Date:  2005-12-29       Impact factor: 11.361

4.  Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.

Authors:  Roman Kulikov; Karen A Boehme; Christine Blattner
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2.

Authors:  Nerea Allende-Vega; Lynsey McKenzie; David Meek
Journal:  Mol Cell Biochem       Date:  2008-06-12       Impact factor: 3.396

6.  The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine.

Authors:  Chad Deisenroth; Yanping Zhang
Journal:  Genes Cancer       Date:  2011-04

Review 7.  Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.

Authors:  Amanda R Wasylishen; Guillermina Lozano
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

8.  Herpes simplex virus type 1 infection induces the stabilization of p53 in a USP7- and ATM-independent manner.

Authors:  Chris Boutell; Roger D Everett
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.

Authors:  Ziyi Wang; Kai Yang; Qiuyu Zheng; Chenting Zhang; Haiyang Tang; Aleksandra Babicheva; Qian Jiang; Meichan Li; Yuqin Chen; Shane G Carr; Kang Wu; Qian Zhang; Angela Balistrieri; Christina Wang; Shanshan Song; Ramon J Ayon; Ankit A Desai; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan; Wenju Lu; Jian Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

10.  Controlling the Mdm2-Mdmx-p53 Circuit.

Authors:  David L Waning; Jason A Lehman; Christopher N Batuello; Lindsey D Mayo
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.